ENTRY       D03360                      Drug
NAME        Diphenhydramine laurylsulfate (JAN);
            Vena (TN)
FORMULA     C12H26O4S. C17H21NO
EXACT_MASS  521.3175
MOL_WEIGHT  521.7522
CLASS       Anti-allergic agent
             DG01557  Histamine receptor antagonist
              DG01482  Histamine receptor H1 antagonist
REMARK      Therapeutic category: 2642
            ATC code: D04AA32 R06AA02
            Chemical structure group: DG00390
            Product (DG00390): D00300<JP> D00669<JP/US> D03360<JP> D00520<JP/US>
EFFICACY    Antiallergic, H1 receptor antagonist
COMMENT     Diphenhydramine derivative
TARGET      HRH1 [HSA:3269] [KO:K04149]
  PATHWAY   hsa04020(3269)  Calcium signaling pathway
            hsa04080(3269)  Neuroactive ligand-receptor interaction
INTERACTION  
STR_MAP     map07028  Antipsychotics
            map07032  Hypnotics
            map07212  Histamine H1 receptor antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             D DERMATOLOGICALS
              D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
               D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
                D04AA Antihistamines for topical use
                 D04AA32 Diphenhydramine
                  D03360  Diphenhydramine laurylsulfate (JAN) &lt;JP&gt;
             R RESPIRATORY SYSTEM
              R06 ANTIHISTAMINES FOR SYSTEMIC USE
               R06A ANTIHISTAMINES FOR SYSTEMIC USE
                R06AA Aminoalkyl ethers
                 R06AA02 Diphenhydramine
                  D03360  Diphenhydramine laurylsulfate (JAN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              26  Epidermides
               264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
                2642  Antihistamines for external use
                 D03360  Diphenhydramine laurylsulfate (JAN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for integumentary system
              57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
               D03360  Diphenhydramine laurylsulfate (JAN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Third-class OTC drugs
              Inorganic and organic chemicals
               Diphenhydramine
                D03360  Diphenhydramine laurylsulfate (JAN)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00390  Diphenhydramine
                 D03360  Diphenhydramine laurylsulfate
            Drug classes [BR:br08332]
             Anti-allergic agent
              DG01482  Histamine receptor H1 antagonist
               D03360  Diphenhydramine laurylsulfate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH1
                 D03360  Diphenhydramine laurylsulfate (JAN) &lt;JP&gt;
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01557  Histamine receptor antagonist
               DG01482  Histamine receptor H1 antagonist
                DG00390  Diphenhydramine
DBLINKS     PubChem: 17397509
            LigandBox: D03360
ATOM        36
            1   C1c C    20.7534  -18.7629
            2   C8y C    19.5421  -19.4675
            3   C8y C    21.9707  -19.4675
            4   O2a O    20.7593  -17.3651
            5   C8x C    19.5421  -20.8712
            6   C8x C    18.3306  -18.7629
            7   C8x C    21.9650  -20.8712
            8   C8x C    23.1762  -18.7629
            9   C1b C    21.9707  -16.6604
            10  C8x C    18.3306  -21.5641
            11  C8x C    17.1133  -19.4675
            12  C8x C    23.1762  -21.5641
            13  C8x C    24.3935  -19.4675
            14  C8x C    17.1133  -20.8712
            15  C8x C    24.3876  -20.8712
            16  C1b C    23.2072  -17.3717
            17  N1c N    24.4042  -16.6780
            18  C1a C    25.5940  -17.3624
            19  C1a C    24.4020  -15.2685
            20  C1b C    43.4700  -19.3900
            21  C1b C    42.2800  -20.0900
            22  C1b C    41.0900  -19.3900
            23  C1b C    39.8300  -20.0900
            24  C1b C    38.6400  -19.3900
            25  C1b C    37.4500  -20.0900
            26  C1b C    36.2600  -19.3900
            27  C1b C    35.0700  -20.0900
            28  C1b C    33.8100  -19.3900
            29  C1b C    32.6200  -20.0900
            30  C1b C    31.4300  -19.3900
            31  O2a O    30.2400  -20.0900
            32  C1a C    44.7300  -20.0900
            33  S4a S    28.8400  -20.0900
            34  O1d O    27.4400  -20.0900
            35  O1d O    28.8400  -18.6900
            36  O1d O    28.8400  -21.4900
BOND        36
            1     5  10 2
            2     6  11 1
            3     7  12 1
            4     8  13 2
            5    10  14 1
            6    12  15 2
            7    11  14 2
            8    13  15 1
            9     1   2 1
            10    1   3 1
            11    1   4 1
            12    2   5 1
            13    2   6 2
            14    3   7 2
            15    3   8 1
            16    4   9 1
            17    9  16 1
            18   16  17 1
            19   17  18 1
            20   17  19 1
            21   20  21 1
            22   21  22 1
            23   22  23 1
            24   23  24 1
            25   24  25 1
            26   25  26 1
            27   26  27 1
            28   27  28 1
            29   28  29 1
            30   29  30 1
            31   30  31 1
            32   20  32 1
            33   31  33 1
            34   33  34 1
            35   33  35 2
            36   33  36 2
///
